SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.v71.3 http://doi.org/10.3322/caac.v71.3 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/71/3 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/71/3

World Health Organization . Cancer topics [EB/OL ] .[2023-08-11 ] . https://www.iarc.who.int/cancer-topics/. https://www.iarc.who.int/cancer-topics/ https://www.iarc.who.int/cancer-topics/

CHEN M , ZHAO H Y . Next-generation sequencing in liquid biopsy: cancer screening and early detection [J ] . Hum Genomics , 2019 , 13 ( 1 ): 34 . DOI: 10.1186/s40246-019-0220-8 http://doi.org/10.1186/s40246-019-0220-8

GUZAUSKAS G F , GARBETT S , ZHOU Z L , et al . Population genomic screening for three common hereditary conditions: a cost-effectiveness analysis [J ] . Ann Intern Med , 2023 , 176 ( 5 ): 585 - 595 . DOI: 10.7326/M22-0846 http://doi.org/10.7326/M22-0846 https://www.acpjournals.org/doi/10.7326/M22-0846 https://www.acpjournals.org/doi/10.7326/M22-0846

DEVLIN L A , MORRISON P J . Inherited gynaecological cancer syndromes [J ] . Obstet Gynaecol , 2008 , 10 ( 1 ): 9 - 15 . DOI: 10.1576/toag.10.1.009.27371 http://doi.org/10.1576/toag.10.1.009.27371 https://obgyn.onlinelibrary.wiley.com/doi/10.1576/toag.10.1.009.27371 https://obgyn.onlinelibrary.wiley.com/doi/10.1576/toag.10.1.009.27371

Hereditary cancer syndromes and risk assessment: ACOG COMMITTEE OPINION, number 793 [J ] . Obstet Gynecol , 2019 , 134 ( 6 ): e143 -e149. DOI: 10.1097/AOG.0000000000003563 http://doi.org/10.1097/AOG.0000000000003563

KOSTOV S , WATROWSKI R , KORNOVSKI Y , et al . Hereditary gynecologic cancer syndromes-a narrative review [J ] . Onco Targets Ther , 2022 , 15 : 381 - 405 . DOI: 10.2147/OTT.S353054 http://doi.org/10.2147/OTT.S353054 https://www.dovepress.com/hereditary-gynecologic-cancer-syndromes--a-narrative-review-peer-reviewed-fulltext-article-OTT https://www.dovepress.com/hereditary-gynecologic-cancer-syndromes--a-narrative-review-peer-reviewed-fulltext-article-OTT

MURRAY M F , KHOURY M J , ABUL-HUSN N S . Addressing the routine failure to clinically identify monogenic cases of common disease [J ] . Genome Med , 2022 , 14 ( 1 ): 60 . DOI: 10.1186/s13073-022-01062-6 http://doi.org/10.1186/s13073-022-01062-6

RANDALL L M , POTHURI B . The genetic prediction of risk for gynecologic cancers [J ] . Gynecol Oncol , 2016 , 141 ( 1 ): 10 - 16 . DOI: 10.1016/j.ygyno.2016.03.007 http://doi.org/10.1016/j.ygyno.2016.03.007

FANALE D , PIVETTI A , CANCELLIERE D , et al . BRCA 1/2 variants of unknown significance in hereditary breast and ovarian c ancer (HBOC) syndrome: looking for the hidden meaning [J ] . Crit Rev Oncol Hematol , 2022 , 172 : 103626 . DOI: 10.1016/j.critrevonc.2022.103626 http://doi.org/10.1016/j.critrevonc.2022.103626 https://linkinghub.elsevier.com/retrieve/pii/S1040842822000506 https://linkinghub.elsevier.com/retrieve/pii/S1040842822000506

LU K H . Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis [J ] . Fam Cancer , 2008 , 7 ( 1 ): 53 - 58 . DOI: 10.1007/s10689-007-9144-x http://doi.org/10.1007/s10689-007-9144-x

SHANBHOGUE K P , PRASAD A S , UCISIK-KESER F E , et al . Hereditary ovarian tumour syndromes: current update on genetics and imaging [J ] . Clin Radiol , 2021 , 76 ( 4 ): 313. e15 - 313 .313.e26.

UEKI A , HIRASAWA A . Molecular features and clinical management of hereditary gynecological cancers [J ] . Int J Mol Sci , 2020 , 21 ( 24 ): 9504 . DOI: 10.3390/ijms21249504 http://doi.org/10.3390/ijms21249504 https://www.mdpi.com/1422-0067/21/24/9504 https://www.mdpi.com/1422-0067/21/24/9504

KATABATHINA V S , MENIAS C O , KHANNA L , et al . Hereditary gastrointestinal cancer syndromes: role of imaging in screening, diagnosis, and management [J ] . Radiographics , 2019 , 39 ( 5 ): 1280 - 1301 . DOI: 10.1148/rg.2019180185 http://doi.org/10.1148/rg.2019180185

MANNING-GEIST B L , GATIUS S , LIU Y , et al . Diagnosis and management of an endometrial cancer patient with Cowden syndrome [J ] . Gynecol Oncol , 2021 , 163 ( 1 ): 14 - 21 . DOI: 10.1016/j.ygyno.2021.08.008 http://doi.org/10.1016/j.ygyno.2021.08.008 https://linkinghub.elsevier.com/retrieve/pii/S0090825821012920 https://linkinghub.elsevier.com/retrieve/pii/S0090825821012920

LU G H . Hereditary cancer genetic counseling [M ] . Beijing : Peking University Medical Press , 2021 : 261 - 292 .

NEMES K , FRÜHWALD M C . Emerging therapeutic targets for the treatment of malignant rhabdoid tumors [J ] . Expert Opin Ther Targets , 2018 , 22 ( 4 ): 365 - 379 . DOI: 10.1080/14728222.2018.1451839 http://doi.org/10.1080/14728222.2018.1451839 https://www.tandfonline.com/doi/full/10.1080/14728222.2018.1451839 https://www.tandfonline.com/doi/full/10.1080/14728222.2018.1451839

SCHULTZ K A P , STEWART D R , KAMIHARA J , et al . DICER1 Tumor Predisposition [DB/OL ] . (2020-04-30)[2023-08-11 ] . https://www.ncbi.nlm.nih.gov/books/NBK196157/. https://www.ncbi.nlm.nih.gov/books/NBK196157/ https://www.ncbi.nlm.nih.gov/books/NBK196157/

DHO Y S , KIM S K , CHEON J E , et al . Investigation of the location of atypical teratoid/rhabdoid tumor [J ] . Childs Nerv Syst , 2015 , 31 ( 8 ): 1305 - 1311 . DOI: 10.1007/s00381-015-2739-x http://doi.org/10.1007/s00381-015-2739-x http://link.springer.com/10.1007/s00381-015-2739-x http://link.springer.com/10.1007/s00381-015-2739-x

LINDOR N M , MCMASTER M L , LINDOR C J , et al . Concise handbook of familial cancer susceptibility syndromes-second edition [J ] . J Natl Cancer Inst Monogr , 2008 ( 38 ): 1 - 93 .

HILGART J S , HAYWARD J A , COLES B , et al . Telegenetics: a systematic review of telemedicine in genetics services [J ] . Genet Med , 2012 , 14 ( 9 ): 765 - 776 . DOI: 10.1038/gim.2012.40 http://doi.org/10.1038/gim.2012.40

BAUMANIS L , EVANS J P , CALLANAN N , et al . Telephoned BRCA 1/2 genetic test results: prevalence, practice, and patient satisfaction [J ] . J Genet Couns , 2009 , 18 ( 5 ): 447 - 463 . DOI: 10.1007/s10897-009-9238-8 http://doi.org/10.1007/s10897-009-9238-8 https://onlinelibrary.wiley.com/doi/10.1007/s10897-009-9238-8 https://onlinelibrary.wiley.com/doi/10.1007/s10897-009-9238-8

GRAY J , BRAIN K , IREDALE R , et al . A pilot study of telegenetics [J ] . J Telemed Telecare , 2000 , 6 ( 4 ): 245 - 247 .

KINNEY A Y , BUTLER K M , SCHWARTZ M D , et al . Expanding access to BRCA 1/2 genetic counseling with telephone delivery: a cluster randomized trial [J ] . J Natl Cancer Inst , 2014 , 106 ( 12 ): dju328 . DOI: 10.1093/jnci/dju328 http://doi.org/10.1093/jnci/dju328 https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/dju328 https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/dju328

BRACKE X , ROBERTS J , MCVEIGH T P . A systematic review and meta-analysis of telephone vs in-person genetic counseling in BRCA 1/ BRCA 2 genetic testing [J ] . J Genet Couns , 2021 , 30 ( 2 ): 563 - 573 . DOI: 10.1002/jgc4.v30.2 http://doi.org/10.1002/jgc4.v30.2 https://onlinelibrary.wiley.com/toc/15733599/30/2 https://onlinelibrary.wiley.com/toc/15733599/30/2

GATTAS M R , MACMILLAN J C , MEINECKE I , et al . Telemedicine and clinical genetics: establishing a successful service [J ] . J Telemed Telecare , 2001 , 7 ( Suppl 2 ): 68 - 70 .

COELHO J J , ARNOLD A , NAYLER J , et al . An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations [J ] . Eur J Cancer , 2005 , 41 ( 15 ): 2257 - 2261 .

ZILLIACUS E M , MEISER B , LOBB E A , et al . Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? [J ] . Genet Med , 2011 , 13 ( 11 ): 933 - 941 . DOI: 10.1097/GIM.0b013e3182217a19 http://doi.org/10.1097/GIM.0b013e3182217a19

SENTER L , O’MALLEY D M , BACKES F J , et al . Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care [J ] . Gynecol Oncol , 2017 , 147 ( 1 ): 110 - 114 . DOI: S0090-8258(17)31182-4 http://doi.org/S0090-8258(17)31182-4

RANA H Q , KIPNIS L , HEHIR K , et al . Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer [J ] . Gynecol Oncol , 2021 , 160 ( 2 ): 457 - 463 . DOI: 10.1016/j.ygyno.2020.11.003 http://doi.org/10.1016/j.ygyno.2020.11.003

KENTWELL M , DOW E , ANTILL Y , et al . Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics [J ] . Gynecol Oncol , 2017 , 145 ( 1 ): 130 - 136 .

MÁRQUEZ-RODAS I , LÓPEZ-TRABADA D , RUPÉREZ BLANCO A B , et al . Family history record and hereditary cancer risk perception according to National Cancer Institute criteria in a Spanish medical oncology service: a retrospective study [J ] . Oncology , 2012 , 82 ( 1 ): 30 - 34 . DOI: 10.1159/000335960 http://doi.org/10.1159/000335960 https://www.karger.com/Article/FullText/335960 https://www.karger.com/Article/FullText/335960

OW S G , YONG Y F , CHIENG W S , et al . Inadequate family history assessment by oncologists is an important physician barrier to referral for hereditary breast cancer evaluation [J ] . Clin Oncol (R Coll Radiol) , 2014 , 26 ( 3 ): 174 - 175 . DOI: 10.1016/j.clon.2013.11.029 http://doi.org/10.1016/j.clon.2013.11.029

BORRY P , STULTIENS L , NYS H , et al . Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers [J ] . Clin Genet , 2006 , 70 ( 5 ): 374 - 381 .

EIJZENGA W , DE GEUS E , AALFS C M , et al . How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial [J ] . Patient Educ Couns , 2018 , 101 ( 9 ): 1611 - 1619 . DOI: S0738-3991(18)30206-4 http://doi.org/S0738-3991(18)30206-4

OFFIT K , LEVRAN O , MULLANEY B , et al . Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia [J ] . J Natl Cancer Inst , 2003 , 95 ( 20 ): 1548 - 1551 .

FANALE D , FIORINO A , INCORVAIA L , et al . Prevalence and spectrum of germline BRCA 1 and BRCA 2 variants of uncertain significance in breast/ovarian cancer: mysterious signals from the genome [J ] . Front Oncol , 2021 , 11 : 682445 . DOI: 10.3389/fonc.2021.682445 http://doi.org/10.3389/fonc.2021.682445 https://www.frontiersin.org/articles/10.3389/fonc.2021.682445/full https://www.frontiersin.org/articles/10.3389/fonc.2021.682445/full

HEGDE M , FERBER M , MAO R , et al . ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis) [J ] . Genet Med , 2014 , 16 ( 1 ): 101 - 116 . DOI: 10.1038/gim.2013.166 http://doi.org/10.1038/gim.2013.166

《基于下一代测序技术的 BRCA 1/2基因检测指南(2019版)》编写组 . 基于下一代测序技术的 BRCA 1/2基因检测指南(2019版) [J ] . 中华病理学杂志 , 2019 , 48 ( 9 ): 670 - 677 .

“Guidelines for genetic testing of BRCA 1/2 genes based on next-generation sequencing technology (2019 edition)” Working Group . Guidelines for genetic testing of BRCA 1/2 genes based on next-generation sequencing technology (2019 edition) [J ] . Chin J Pathol , 2019 , 48 ( 9 ): 670 - 677 .

MILLER D T , LEE K , ABUL-HUSN N S , et al . ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) [J ] . Genet Med , 2022 , 24 ( 7 ): 1407 - 1414 . DOI: 10.1016/j.gim.2022.04.006 http://doi.org/10.1016/j.gim.2022.04.006

REHDER C , BEAN L J H , BICK D , et al . Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) [J ] . Genet Med , 2021 , 23 ( 8 ): 1399 - 1415 . DOI: 10.1038/s41436-021-01139-4 http://doi.org/10.1038/s41436-021-01139-4

SONG C , DUZKALE H , SHEN J . Reporting of clinical genome sequencing results [J ] . Curr Protoc Hum Genet , 2018 , 98 ( 1 ): e61 .

张军玉 , 沈亦平 . 全面认识遗传检测 [J ] . 中国实用儿科杂志 , 2022 , 37 ( 4 ): 272 - 276 .

ZHANG J Y , SHEN Y P . A comprehensive understanding of genetic testing [J ] . Chin J Pract Pediatr , 2022 , 37 ( 4 ): 272 - 276 .

GAYTHER S A , PHAROAH P D P . The inherited genetics of ovarian and endometrial cancer [J ] . Curr Opin Genet Dev , 2010 , 20 ( 3 ): 231 - 238 . DOI: 10.1016/j.gde.2010.03.001 http://doi.org/10.1016/j.gde.2010.03.001

JONES M A , TIMMS K M , HATCHER S , et al . The landscape of BRCA 1 and BRCA 2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencing [J ] . Genes Chromosomes Cancer , 2023 , 62 ( 10 ): 589 - 596 . DOI: 10.1002/gcc.v62.10 http://doi.org/10.1002/gcc.v62.10 https://onlinelibrary.wiley.com/toc/10982264/62/10 https://onlinelibrary.wiley.com/toc/10982264/62/10

FAYER S , HORTON C , DINES J N , et al . Closing the gap: systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA 1, TP 53, and PTEN [J ] . Am J Hum Genet , 2021 , 108 ( 12 ): 2248 - 2258 . DOI: 10.1016/j.ajhg.2021.11.001 http://doi.org/10.1016/j.ajhg.2021.11.001 https://linkinghub.elsevier.com/retrieve/pii/S0002929721004110 https://linkinghub.elsevier.com/retrieve/pii/S0002929721004110

RICHARDS S , AZIZ N , BALE S , et al . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology [J ] . Genet Med , 2015 , 17 ( 5 ): 405 - 424 . DOI: 10.1038/gim.2015.30 http://doi.org/10.1038/gim.2015.30

TAVTIGIAN S V , HARRISON S M , BOUCHER K M , et al . Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines [J ] . Hum Mutat , 2020 , 41 ( 10 ): 1734 - 1737 . DOI: 10.1002/humu.v41.10 http://doi.org/10.1002/humu.v41.10 https://onlinelibrary.wiley.com/toc/10981004/41/10 https://onlinelibrary.wiley.com/toc/10981004/41/10

MERSCH J , BROWN N , PIRZADEH-MILLER S , et al . Prevalence of variant reclassification following hereditary cancer genetic testing [J ] . JAMA , 2018 , 320 ( 12 ): 1266 - 1274 . DOI: 10.1001/jama.2018.13152 http://doi.org/10.1001/jama.2018.13152

ESTERLING L , WIJAYATUNGE R , BROWN K , et al . Impact of a cancer gene variant reclassification program over a 20-year period [J ] . JCO Precis Oncol , 2020 , 4: PO.20.00020.

ZHANG J , YAO Y , HE H , et al . Clinical interpretation of sequence variants [J ] . Curr Protoc Hum Genet , 2020 , 106 ( 1 ): e98 .

KATZ A E , NUSSBAUM R L , SOLOMON B D , et al . Management of secondary genomic findings [J ] . Am J Hum Genet , 2020 , 107 ( 1 ): 3 - 14 . DOI: S0002-9297(20)30149-X http://doi.org/S0002-9297(20)30149-X

MURRAY M F , GIOVANNI M A , DOYLE D L , et al . DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG) [J ] . Genet Med , 2021 , 23 ( 6 ): 989 - 995 . DOI: 10.1038/s41436-020-01082-w http://doi.org/10.1038/s41436-020-01082-w

KOTSOPOULOS J , GRONWALD J , KARLAN B , et al . Age-specific ovarian cancer risks among women with a BRCA 1 or BRCA 2 mutation [J ] . Gynecol Oncol , 2018 , 150 ( 1 ): 85 - 91 . DOI: 10.1016/j.ygyno.2018.05.011 http://doi.org/10.1016/j.ygyno.2018.05.011 https://linkinghub.elsevier.com/retrieve/pii/S0090825818308989 https://linkinghub.elsevier.com/retrieve/pii/S0090825818308989

ANTONIOU A , PHAROAH P D , NAROD S , et al . Average risks of breast and ovarian cancer associated with BRCA 1 or BRCA 2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies [J ] . Am J Hum Genet , 2003 , 72 ( 5 ): 1117 - 1130 . DOI: 10.1086/375033 http://doi.org/10.1086/375033 https://linkinghub.elsevier.com/retrieve/pii/S0002929707606405 https://linkinghub.elsevier.com/retrieve/pii/S0002929707606405

CHEN S N , IVERSEN E S , FRIEBEL T , et al . Characterization of BRCA 1 and BRCA 2 mutations in a large United States sample [J ] . J Clin Oncol , 2006 , 24 ( 6 ): 863 - 871 . DOI: 10.1200/JCO.2005.03.6772 http://doi.org/10.1200/JCO.2005.03.6772 https://ascopubs.org/doi/10.1200/JCO.2005.03.6772 https://ascopubs.org/doi/10.1200/JCO.2005.03.6772

BROSE M S , REBBECK T R , CALZONE K A , et al . Cancer risk estimates for BRCA 1 mutation carriers identified in a risk evaluation program [J ] . J Natl Cancer Inst , 2002 , 94 ( 18 ): 1365 - 1372 . DOI: 10.1093/jnci/94.18.1365 http://doi.org/10.1093/jnci/94.18.1365 https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/94.18.1365 https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/94.18.1365

VAN ASPEREN C J , BROHET R M , MEIJERS-HEIJBOER E J , et al . Cancer risks in BRCA 2 families: estimates for sites other than breast and ovary [J ] . J Med Genet , 2005 , 42 ( 9 ): 711 - 719 . DOI: 10.1136/jmg.2004.028829 http://doi.org/10.1136/jmg.2004.028829 https://jmg.bmj.com/lookup/doi/10.1136/jmg.2004.028829 https://jmg.bmj.com/lookup/doi/10.1136/jmg.2004.028829

CHEN S N , PARMIGIANI G . Meta-analysis of BRCA 1 and BRCA 2 penetrance [J ] . J Clin Oncol , 2007 , 25 ( 11 ): 1329 - 1333 . DOI: 10.1200/JCO.2006.09.1066 http://doi.org/10.1200/JCO.2006.09.1066 https://ascopubs.org/doi/10.1200/JCO.2006.09.1066 https://ascopubs.org/doi/10.1200/JCO.2006.09.1066

MAVADDAT N , PEOCK S , FROST D , et al . Cancer risks for BRCA 1 and BRCA 2 mutation carriers: results from prospective analysis of EMBRACE [J ] . J Natl Cancer Inst , 2013 , 105 ( 11 ): 812 - 822 . DOI: 10.1093/jnci/djt095 http://doi.org/10.1093/jnci/djt095 https://academic.oup.com/jnci/article/105/11/812/1004115 https://academic.oup.com/jnci/article/105/11/812/1004115

KUCHENBAECKER K B , HOPPER J L , BARNES D R , et al . Risks of breast, ovarian, and contralateral breast cancer for BRCA 1 and BRCA 2 mutation carriers [J ] . JAMA , 2017 , 317 ( 23 ): 2402 - 2416 . DOI: 10.1001/jama.2017.7112 http://doi.org/10.1001/jama.2017.7112 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2017.7112 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2017.7112

SEPPÄLÄ T T , DOMINGUEZ-VALENTIN M , SAMPSON J R , et al . Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD) [J ] . Fam Cancer , 2021 , 20 ( 1 ): 35 - 39 . DOI: 10.1007/s10689-020-00193-2 http://doi.org/10.1007/s10689-020-00193-2

HELDER-WOOLDERINK J M , BLOK E A , VASEN H F , et al . Ovarian cancer in Lynch syndrome; a systematic review [J ] . Eur J Cancer , 2016 , 55 : 65 - 73 . DOI: 10.1016/j.ejca.2015.12.005 http://doi.org/10.1016/j.ejca.2015.12.005 https://linkinghub.elsevier.com/retrieve/pii/S0959804915011399 https://linkinghub.elsevier.com/retrieve/pii/S0959804915011399

DOWTY J G , WIN A K , BUCHANAN D D , et al . Cancer risks for MLH 1 and MSH 2 mutation carriers [J ] . Hum Mutat , 2013 , 34 ( 3 ): 490 - 497 . DOI: 10.1002/humu.22262 http://doi.org/10.1002/humu.22262 https://onlinelibrary.wiley.com/doi/10.1002/humu.22262 https://onlinelibrary.wiley.com/doi/10.1002/humu.22262

BONADONA V , BONAÏTI B , OLSCHWANG S , et al . Cancer risks associated with germline mutations in MLH 1, MSH 2, and MSH 6 genes in Lynch syndrome [J ] . JAMA , 2011 , 305 ( 22 ): 2304 - 2310 . DOI: 10.1001/jama.2011.743 http://doi.org/10.1001/jama.2011.743 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2011.743 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2011.743

DOMINGUEZ-VALENTIN M , SAMPSON J R , SEPPÄLÄ T T , et al . Cancer risks by gene, age, and gender in 6 350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database [J ] . Genet Med , 2020 , 22 ( 1 ): 15 - 25 .

MESERVE E E K , NUCCI M R . Peutz-Jeghers syndrome: pathobiology, pathologic manifestations, and suggestions for recommending genetic testing in pathology reports [J ] . Surg Pathol Clin , 2016 , 9 ( 2 ): 243 - 268 . DOI: 10.1016/j.path.2016.01.006 http://doi.org/10.1016/j.path.2016.01.006

ISHIDA H , TAJIMA Y , GONDA T , et al . Update on our investigation of malignant tumors associated with Peutz-Jeghers syndrome in Japan [J ] . Surg Today , 2016 , 46 ( 11 ): 1231 - 1242 . DOI: 10.1007/s00595-015-1296-y http://doi.org/10.1007/s00595-015-1296-y

TAN M H , MESTER J L , NGEOW J , et al . Lifetime cancer risks in individuals with germline PTEN mutations [J ] . Clin Cancer Res , 2012 , 18 ( 2 ): 400 - 407 . DOI: 10.1158/1078-0432.CCR-11-2283 http://doi.org/10.1158/1078-0432.CCR-11-2283 https://aacrjournals.org/clincancerres/article/18/2/400/77281/Lifetime-Cancer-Risks-in-Individuals-with-Germline https://aacrjournals.org/clincancerres/article/18/2/400/77281/Lifetime-Cancer-Risks-in-Individuals-with-Germline

RAMUS S J , SONG H L , DICKS E , et al . Germline mutations in the BRIP 1, BARD 1, PALB 2, and NBN genes in women with ovarian cancer [J ] . J Natl Cancer Inst , 2015 , 107 ( 11 ): djv214 .

KEMPERS M J , KUIPER R P , OCKELOEN C W , et al . Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study [J ] . Lancet Oncol , 2011 , 12 ( 1 ): 49 - 55 . DOI: 10.1016/S1470-2045(10)70265-5 http://doi.org/10.1016/S1470-2045(10)70265-5 https://linkinghub.elsevier.com/retrieve/pii/S1470204510702655 https://linkinghub.elsevier.com/retrieve/pii/S1470204510702655

YANG X , SONG H L , LESLIE G , et al . Ovarian and breast cancer risks associated with pathogenic variants in RAD 51 C and RAD 51 D [J ] . J Natl Cancer Inst , 2020 , 112 ( 12 ): 1242 - 1250 . DOI: 10.1093/jnci/djaa030 http://doi.org/10.1093/jnci/djaa030 https://academic.oup.com/jnci/article/112/12/1242/5764125 https://academic.oup.com/jnci/article/112/12/1242/5764125

GOGGINS M , OVERBEEK K A , BRAND R , et al . Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium [J ] . Gut , 2020 , 69 ( 1 ): 7 - 17 . DOI: 10.1136/gutjnl-2019-319352 http://doi.org/10.1136/gutjnl-2019-319352

HAN F F , GUO C L , LIU L H . The effect of CHEK 2 variant I157T on cancer susceptibility: evidence from a meta-analysis [J ] . DNA Cell Biol , 2013 , 32 ( 6 ): 329 - 335 . DOI: 10.1089/dna.2013.1970 http://doi.org/10.1089/dna.2013.1970 http://www.liebertpub.com/doi/10.1089/dna.2013.1970 http://www.liebertpub.com/doi/10.1089/dna.2013.1970

JACOBS I J , MENON U , RYAN A , et al . Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial [J ] . Lancet , 2016 , 387 ( 10022 ): 945 - 956 . DOI: S0140-6736(15)01224-6 http://doi.org/S0140-6736(15)01224-6

MENON U , GENTRY-MAHARAJ A , HALLETT R , et al . Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) [J ] . Lancet Oncol , 2009 , 10 ( 4 ): 327 - 340 . DOI: 10.1016/S1470-2045(09)70026-9 http://doi.org/10.1016/S1470-2045(09)70026-9

ROSENTHAL A N , FRASER L S M , PHILPOTT S , et al . Evidence of stage shift in women diagnosed with ovarian cancer during phase Ⅱ of the United Kingdom familial ovarian cancer screening study [J ] . J Clin Oncol , 2017 , 35 ( 13 ): 1411 - 1420 . DOI: 10.1200/JCO.2016.69.9330 http://doi.org/10.1200/JCO.2016.69.9330 https://ascopubs.org/doi/10.1200/JCO.2016.69.9330 https://ascopubs.org/doi/10.1200/JCO.2016.69.9330

SKATES S J , GREENE M H , BUYS S S , et al . Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA12-5 testing in women at increased familial risk-combined results from two screening trials [J ] . Clin Cancer Res , 2017 , 23 ( 14 ): 3628 - 3637 . DOI: 10.1158/1078-0432.CCR-15-2750 http://doi.org/10.1158/1078-0432.CCR-15-2750 https://aacrjournals.org/clincancerres/article/23/14/3628/123185/Early-Detection-of-Ovarian-Cancer-using-the-Risk https://aacrjournals.org/clincancerres/article/23/14/3628/123185/Early-Detection-of-Ovarian-Cancer-using-the-Risk

National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology (NCCN guidelines®) genetic/familial high-risk assessment: colorectal version 1.2022 [EB/OL ] . (2023-02-10)[2023-08-11 ] . https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf

JACOBS I , GENTRY-MAHARAJ A , BURNELL M , et al . Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort [J ] . Lancet Oncol , 2011 , 12 ( 1 ): 38 - 48 . DOI: 10.1016/S1470-2045(10)70268-0 http://doi.org/10.1016/S1470-2045(10)70268-0

DOVE-EDWIN I , BOKS D , GOFF S , et al . The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma [J ] . Cancer , 2002 , 94 ( 6 ): 1708 - 1712 . DOI: 10.1002/cncr.v94:6 http://doi.org/10.1002/cncr.v94:6 https://acsjournals.onlinelibrary.wiley.com/toc/10970142/94/6 https://acsjournals.onlinelibrary.wiley.com/toc/10970142/94/6

RENKONEN-SINISALO L , BÜTZOW R , LEMINEN A , et al . Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome [J ] . Int J Cancer , 2007 , 120 ( 4 ): 821 - 824 . DOI: 10.1002/ijc.v120:4 http://doi.org/10.1002/ijc.v120:4 https://onlinelibrary.wiley.com/toc/10970215/120/4 https://onlinelibrary.wiley.com/toc/10970215/120/4

SROCZYNSKI G , GOGOLLARI A , CONRADS-FRANK A , et al . Cost-effectiveness of early detection and prevention strategies for endometrial cancer-a systematic review [J ] . Cancers (Basel) , 2020 , 12 ( 7 ): 1874 . DOI: 10.3390/cancers12071874 http://doi.org/10.3390/cancers12071874 https://www.mdpi.com/2072-6694/12/7/1874 https://www.mdpi.com/2072-6694/12/7/1874

LEE M H , KIM E S , CHOI M C , et al . Minimal deviation adenocarcinoma (adenoma malignum) of the uterine cervix: clinicopathological analysis of 17 cases [J ] . Obstet Gynecol Sci , 2018 , 61 ( 5 ): 590 - 597 . DOI: 10.5468/ogs.2018.61.5.590 http://doi.org/10.5468/ogs.2018.61.5.590

王文莉 , 叶红 . Peutz-Jeghers综合征相关宫颈胃型腺癌的研究进展 [J ] . 中国微创外科杂志 , 2022 , 22 ( 2 ): 167 - 169 .

WANG W L , YE H . Research progress of cervical gastric type adenocarcinoma associated with Peutz-Jeghers syndrome [J ] . Chin J Min Inv Surg , 2022 , 22 ( 2 ): 167 - 169 .

PATNICK J , LANCUCKI L . Cervical screening programme, England: 1997-1998 [J ] . J Med Screen , 1999 , 6 ( 2 ): 57 . DOI: 10.1136/jms.6.2.57 http://doi.org/10.1136/jms.6.2.57 http://journals.sagepub.com/doi/10.1136/jms.6.2.57 http://journals.sagepub.com/doi/10.1136/jms.6.2.57

SENGUPTA S , BOSE S . Peutz-Jeghers syndrome [J ] . N Engl J Med , 2019 , 380 ( 5 ): 472 . DOI: 10.1056/NEJMicm1806623 http://doi.org/10.1056/NEJMicm1806623 http://www.nejm.org/doi/10.1056/NEJMicm1806623 http://www.nejm.org/doi/10.1056/NEJMicm1806623

MONK B J , PARKINSON C , LIM M C , et al . A randomized, phase Ⅲ trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45) [J ] . J Clin Oncol , 2022 , 40 ( 34 ): 3952 - 3964 . DOI: 10.1200/JCO.22.01003 http://doi.org/10.1200/JCO.22.01003 https://ascopubs.org/doi/10.1200/JCO.22.01003 https://ascopubs.org/doi/10.1200/JCO.22.01003

OAKNIN A , GILBERT L , TINKER A V , et al . Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase Ⅰ, single-arm study [J ] . J Immunother Cancer , 2022 , 10 ( 1 ): e003777 . DOI: 10.1136/jitc-2021-003777 http://doi.org/10.1136/jitc-2021-003777 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-003777 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-003777

PETERS S , CHO B C , LUFT A , et al . Association between KRAS / STK 11/ KEAP 1 mutations and outcomes in POSEIDON: durvalumab±tremelimumab+chemotherapy in mNSCLC [C ] . Vienna:2022 World Conference on Lung Cancer , 2022 : abstract 1220 .

ELEJE G U , EKE A C , EZEBIALU I U , et al . Risk-reducing bilateral salpingo-oophorectomy in women with BRCA 1 or BRCA 2 mutations [J ] . Cochrane Database Syst Rev , 2018 , 8 ( 8 ): CD012464 .

LIU Y L , BREEN K , CATCHINGS A , et al . Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes [J ] . JCO Oncol Pract , 2022 , 18 ( 3 ): 201 - 209 .

CHEN L M , BLANK S V , BURTON E , et al . Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: society of gynecologic oncology and American Society for Reproductive Medicine Evidence-based review [J ] . Gynecol Oncol , 2019 , 155 ( 3 ): 508 - 514 . DOI: 10.1016/j.ygyno.2019.06.017 http://doi.org/10.1016/j.ygyno.2019.06.017 https://linkinghub.elsevier.com/retrieve/pii/S0090825819313332 https://linkinghub.elsevier.com/retrieve/pii/S0090825819313332

STANCIU P I , IND T E J , BARTON D P J , et al . Development of peritoneal carcinoma in women diagnosed with serous tubal intraepithelial carcinoma (STIC) following risk-reducing salpingo-oophorectomy (RRSO) [J ] . J Ovarian Res , 2019 , 12 ( 1 ): 50 . DOI: 10.1186/s13048-019-0525-1 http://doi.org/10.1186/s13048-019-0525-1

PINSKY P F , YU K , KRAMER B S , et al . Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up [J ] . Gynecol Oncol , 2016 , 143 ( 2 ): 270 - 275 . DOI: 10.1016/j.ygyno.2016.08.334 http://doi.org/10.1016/j.ygyno.2016.08.334 https://linkinghub.elsevier.com/retrieve/pii/S0090825816313610 https://linkinghub.elsevier.com/retrieve/pii/S0090825816313610

SCHMELER K M , LYNCH H T , CHEN L M , et al . Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome [J ] . N Engl J Med , 2006 , 354 ( 3 ): 261 - 269 . DOI: 10.1056/NEJMoa052627 http://doi.org/10.1056/NEJMoa052627 http://www.nejm.org/doi/abs/10.1056/NEJMoa052627 http://www.nejm.org/doi/abs/10.1056/NEJMoa052627

CAPASSO I , SANTORO A , LUCCI CORDISCO E , et al . Lynch syndrome and gynecologic tumors: incidence, prophylaxis, and management of patients with cancer [J ] . Cancers (Basel) , 2023 , 15 ( 5 ): 1400 . DOI: 10.3390/cancers15051400 http://doi.org/10.3390/cancers15051400 https://www.mdpi.com/2072-6694/15/5/1400 https://www.mdpi.com/2072-6694/15/5/1400

SMERDEL M P , SKYTTE A B , JELSIG A M , et al . Revised Danish guidelines for the cancer surveillance of patients with Cowden Syndrome [J ] . Eur J Med Genet , 2020 , 63 ( 5 ): 103873 . DOI: 10.1016/j.ejmg.2020.103873 http://doi.org/10.1016/j.ejmg.2020.103873 https://linkinghub.elsevier.com/retrieve/pii/S1769721219301338 https://linkinghub.elsevier.com/retrieve/pii/S1769721219301338

SERACCHIOLI R , COLOMBO F M , BAGNOLI A , et al . Primary ovarian leiomyosarcoma as a new component in the nevoid basal cell carcinoma syndrome: a case report [J ] . Am J Obstet Gynecol , 2003 , 188 ( 4 ): 1093 - 1095 .

FOULKES W D , KAMIHARA J , EVANS D G R , et al . Cancer surveillance in gorlin syndrome and rhabdoid tumor predisposition syndrome [J ] . Clin Cancer Res , 2017 , 23 ( 12 ): e62 -e67. DOI: 10.1158/1078-0432.CCR-17-0595 http://doi.org/10.1158/1078-0432.CCR-17-0595 https://aacrjournals.org/clincancerres/article/23/12/e62/80076/Cancer-Surveillance-in-Gorlin-Syndrome-and https://aacrjournals.org/clincancerres/article/23/12/e62/80076/Cancer-Surveillance-in-Gorlin-Syndrome-and

MULLER M , FERLICOT S , GUILLAUD-BATAILLE M , et al . Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers [J ] . Clin Genet , 2017 , 92 ( 6 ): 606 - 615 . DOI: 10.1111/cge.13014 http://doi.org/10.1111/cge.13014

TONOREZOS E S , FRIEDMAN D N , BARNEA D , et al . Recommendations for long-term follow-up of adults with heritable retinoblastoma [J ] . Ophthalmology , 2020 , 127 ( 11 ): 1549 - 1557 . DOI: 10.1016/j.ophtha.2020.05.024 http://doi.org/10.1016/j.ophtha.2020.05.024

SCHRIJVER L H , OLSSON H , PHILLIPS K A , et al . Oral contraceptive use and breast cancer risk: retrospective and prospective analyses from a BRCA 1 and BRCA 2 mutation carrier cohort study [J ] . JNCI Cancer Spectr , 2018 , 2 ( 2 ): pky023 .

SCHRIJVER L H , ANTONIOU A C , OLSSON H , et al . Oral contr aceptive use and ovarian cancer risk for BRCA 1/2 mutation carriers: an international cohort study [J ] . Am J Obstet Gynecol , 2021 , 225 ( 1 ): 51. e1 - 51 .51.e17.

李艳红 , 姚元庆 . 遗传性乳腺癌-卵巢癌综合征 [J ] . 中国实用妇科与产科杂志 , 2006 , 22 ( 9 ): 709 - 710 .

LI Y H , YAO Y Q . Hereditary breast-ovarian cancer syndrome [J ] . Chin J Pract Gynecol Obstet , 2006 , 22 ( 9 ): 709 - 710 .

LU K H , LOOSE D S , YATES M S , et al . Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome [J ] . Cancer Prev Res (Phila) , 2013 , 6 ( 8 ): 774 - 781 . DOI: 10.1158/1940-6207.CAPR-13-0020 http://doi.org/10.1158/1940-6207.CAPR-13-0020 https://aacrjournals.org/cancerpreventionresearch/article/6/8/774/50177/Prospective-Multicenter-Randomized-Intermediate https://aacrjournals.org/cancerpreventionresearch/article/6/8/774/50177/Prospective-Multicenter-Randomized-Intermediate

ANDERSON K , JACOBSON J S , HEITJAN D F , et al . Cost-effectiveness of preventive strategies for women with a BRCA 1 or a BRCA 2 mutation [J ] . Ann Intern Med , 2006 , 144 ( 6 ): 397 - 406 .

GRANN V R , PATEL P R , JACOBSON J S , et al . Comparative effectiveness of screening and prevention strategies among BRCA 1/2-affected mutation carriers [J ] . Breast Cancer Res Treat , 2011 , 125 ( 3 ): 837 - 847 . DOI: 10.1007/s10549-010-1043-4 http://doi.org/10.1007/s10549-010-1043-4 http://link.springer.com/10.1007/s10549-010-1043-4 http://link.springer.com/10.1007/s10549-010-1043-4

BOMMER C , LUPATSCH J , BÜRKI N , et al . Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA -mutation carriers in Switzerland [J ] . Eur J Health Econ , 2022 , 23 ( 5 ): 807 - 821 . DOI: 10.1007/s10198-021-01396-9 http://doi.org/10.1007/s10198-021-01396-9

MANCHANDA R , LEGOOD R , ANTONIOU A C , et al . Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis [J ] . J Med Genet , 2016 , 53 ( 9 ): 591 - 599 . DOI: 10.1136/jmedgenet-2016-103800 http://doi.org/10.1136/jmedgenet-2016-103800 https://jmg.bmj.com/lookup/doi/10.1136/jmedgenet-2016-103800 https://jmg.bmj.com/lookup/doi/10.1136/jmedgenet-2016-103800

MANCHANDA R , LEGOOD R , PEARCE L , et al . Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women [J ] . Gynecol Oncol , 2015 , 139 ( 3 ): 487 - 494 . DOI: 10.1016/j.ygyno.2015.10.001 http://doi.org/10.1016/j.ygyno.2015.10.001

SROCZYNSKI G , GOGOLLARI A , KUEHNE F , et al . A systematic review on cost-effectiveness studies evaluating ovarian cancer early detection and prevention strategies [J ] . Cancer Prev Res (Phila) , 2020 , 13 ( 5 ): 429 - 442 . DOI: 10.1158/1940-6207.CAPR-19-0506 http://doi.org/10.1158/1940-6207.CAPR-19-0506 https://aacrjournals.org/cancerpreventionresearch/article/13/5/429/47395/A-Systematic-Review-on-Cost-effectiveness-Studies https://aacrjournals.org/cancerpreventionresearch/article/13/5/429/47395/A-Systematic-Review-on-Cost-effectiveness-Studies

ZEGERS-HOCHSCHILD F , ADAMSON G D , DYER S , et al . The international glossary on infertility and fertility care, 2017 [J ] . Hum Reprod , 2017 , 32 ( 9 ): 1786 - 1801 . DOI: 10.1093/humrep/dex234 http://doi.org/10.1093/humrep/dex234 https://academic.oup.com/humrep/article/32/9/1786/4049537 https://academic.oup.com/humrep/article/32/9/1786/4049537

GIETEL-HABETS J J , DE DIE-SMULDERS C E , DERKS-SMEETS I A , et al . Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners [J ] . Hum Reprod , 2017 , 32 ( 3 ): 588 - 597 .

DERKS-SMEETS I A , GIETEL-HABETS J J , TIBBEN A , et al . Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer [J ] . Hum Reprod , 2014 , 29 ( 5 ): 1103 - 1112 . DOI: 10.1093/humrep/deu034 http://doi.org/10.1093/humrep/deu034 https://academic.oup.com/humrep/article-lookup/doi/10.1093/humrep/deu034 https://academic.oup.com/humrep/article-lookup/doi/10.1093/humrep/deu034

HODGE J G . Ethical issues concerning genetic testing and screening in public health [J ] . Am J Med Genet C Semin Med Genet , 2004 , 125C ( 1 ): 66 - 70 . DOI: 10.1002/ajmg.c.v125c:1 http://doi.org/10.1002/ajmg.c.v125c:1 https://onlinelibrary.wiley.com/toc/15524876/125C/1 https://onlinelibrary.wiley.com/toc/15524876/125C/1

National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology: genetic/familial high-risk assessment: breast, ovarian, and pancreatic (version 2. 2024) [EB/OL ] . [2023-11-18 ] . https://www.nccn.org. https://www.nccn.org https://www.nccn.org

National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology: genetic/familial high-risk assessment: colorectal (version 2. 2023) [EB/OL ] . [2023-11-18 ] . https://www.nccn.org. https://www.nccn.org https://www.nccn.org

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline [J ] . Ann Oncol , 2023 , 34 ( 1 ): 33 - 47 . DOI: 10.1016/j.annonc.2022.10.004 http://doi.org/10.1016/j.annonc.2022.10.004 https://linkinghub.elsevier.com/retrieve/pii/S092375342204193X https://linkinghub.elsevier.com/retrieve/pii/S092375342204193X

中国抗癌协会家族遗传性肿瘤专业委员会 . 中国家族遗传性肿瘤临床诊疗专家共识(2021年版)(2)—家族遗传性卵巢癌 [J ] . 中国肿瘤临床 , 2021 , 48 ( 24 ): 1243 - 1247 .

Family Genetic Oncology Professional Committee of China Anti-Cancer Association . Consensus of clinical diagnosis and treatment experts on familial hereditary tumors in China (2021 edition) (2)-familial hereditary ovarian cancer [J ] . Chin J Clin Oncol , 2021 , 48 ( 24 ): 1243 - 1247 .

中国医师协会妇产科医师分会妇科肿瘤学组 , 中国初级卫生保健基金会妇科肿瘤专业委员会 . Lynch综合征相关性子宫内膜癌筛查与防治中国专家共识(2023年版) [J ] . 中国实用妇科与产科杂志 , 2023 , 39 ( 1 ): 49 - 57 .

Gynecological Oncology Group of the Obstetricians and Gynecologists Branch of the Chinese Medical Association , Gynecological Oncology Professional Committee of the China Primary Health Care Foundation . Chinese expert consensus on screening, prevention and treatment of Lynch syndrome-related endometrial cancer (2023 edition) [J ] . Chin J Pract Gynecol Obstet , 2023 , 39 ( 1 ): 49 - 57 .

徐丛剑 , 康玉 . 实用妇科肿瘤遗传学 [M ] . 北京 : 人民卫生出版社 , 2019 .

XU C J , KANG Y . Practical Gynecological Tumor Genetics [M ] . Beijing : People’s Medical Publishing House , 2019 .

中国抗癌协会 . 中国肿瘤整合诊治指南(CACA) [M ] . 天津 : 天津科学技术出版社 , 2022 .

China Anti-Cancer Association . CACA guidelines for holistic integrative management of cancer [M ] . Tianjin : Tianjin Science and Technology Press , 2022 .

陆国辉 , 张学 . 遗传性肿瘤遗传咨询 [M ] . 北京 : 北京大学医学出版社 , 2021 .

LU G H , ZHANG X . Genetic counseling for hereditary tumors [M ] . Beijing : Peking University Medical Press , 2021 .